Jeffrey M. Jacobson, MD; Barbara J. Turner, MD; Elias Abrutyn, MD
Potential Financial Conflicts of Interest: Grants received: B. Turner (Pfizer).
Requests for Single Reprints: Jeffrey M. Jacobson, MD, Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, 245 North 15th Street, Mail Stop 461, Philadelphia, PA 19102; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Jacobson: Drexel University College of Medicine, 245 North 15th Street, Mail Stop 461, Philadelphia, PA 19102.
Dr. Turner: Division of General Internal Medicine, University of Pennsylvania School of Medicine, 1123 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021.
Jacobson JM, Turner BJ, Abrutyn E. Trials That Matter: CD4+ T-Lymphocyte Count–Guided Interruption of Antiretroviral Therapy in HIV-Infected Patients. Ann Intern Med. 2007;146:682–683. doi: https://doi.org/10.7326/0003-4819-146-9-200705010-00014
Download citation file:
Published: Ann Intern Med. 2007;146(9):682-683.
HIV, Infectious Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use